Reversible posterior leukoencephalopathy syndrome associated to bevacizumab

被引：3

作者：

Ortiz-Lopez, Esther M. ^{[1
]}

Antonio Gonzalez-Nieto, Jose ^{[1
]}

Rojas-Marcos, Inigo ^{[2
]}

Blanco-Ollero, Alberto ^{[2
]}

机构：

[1] Hosp Juan Ramon Jimenez, UGC Med Interna, E-21005 Huelva, Spain

[2] Hosp Juan Ramon Jimenez, Serv Neurol, E-21005 Huelva, Spain

来源：

REVISTA DE NEUROLOGIA | 2010年 / 51卷 / 02期

关键词：

D O I：

10.33588/rn.5102.2010258

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：117 / 118

页数：2

共 5 条

[1]

Glusker P, 2006, NEW ENGL J MED, V354, P980

[2] Biological mechanisms of bevacizumab-associated adverse events [J].

Higa, Gerald M. ;

Abraham, Jame .

EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (07) :999-1007

[3] A reversible posterior leukoencephalopathy syndrome [J].

Hinchey, J ;

Chaves, C ;

Appignani, B ;

Breen, J ;

Pao, L ;

Wang, A ;

Pessin, MS ;

Lamy, C ;

Mas, JL ;

Caplan, LR .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :494-500

[4] Posterior reversible leukoencephalopathy syndrome caused by pre-eclampsia [J].

Hurtarte-Sandoval, A. R. ;

Saenz-Alegria, R. A. ;

Hernandez-Mejia, J. .

REVISTA DE NEUROLOGIA, 2009, 48 (02) :110-111

[5] Reversible posterior leucoencephalopathy syndrome associated with anticancer drugs [J].

Marinella, M. A. ;

Markert, R. J. .

INTERNAL MEDICINE JOURNAL, 2009, 39 (12) :826-834

← 1 →